ON THE BOARD:  Nazneen Rahman, 51, is made chairman of Astrazeneca’s science committee


City & Finance Reporter for the Daily Mail

The head of genetics at London’s Institute of Cancer Research has been made chairman of Astrazeneca’s science committee.

Nazneen Rahman will also become a member of the nomination and governance committee, the drugs firm said.

The Oxford University graduate was appointed as a director to the company’s board in June 2017. 

An internationally-renowned expert in cancer predisposition genes, Rahman was paid £61,000 in the year to December 31.





Source link